Shinya Sakurai
Overview
Explore the profile of Shinya Sakurai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
168
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang X, Delle C, Peng W, Pla V, Giannetto M, Kusk P, et al.
Neurobiol Dis
. 2023 Oct;
188:106322.
PMID: 37832797
The ocular glymphatic system supports bidirectional fluid transport along the optic nerve, thereby removes metabolic wastes including amyloid-β. To better understand this biological process, we examined the distributions of intravitreally...
2.
Boivin N, Sakurai S
Med Teach
. 2023 Aug;
46(6):852-853.
PMID: 37572652
There has been a rise in the amount of medical schools in the United States and Canada that are offering 3-year programs to graduation. From a student perspective, there are...
3.
Okubo Y, Umezawa Y, Sakurai S, Hoshii N, Nakagawa H
Dermatol Ther (Heidelb)
. 2022 May;
12(6):1397-1415.
PMID: 35622315
Introduction: We report an exploratory analysis of the efficacy and safety of certolizumab pegol (CZP) in Japanese patients with generalized pustular psoriasis (GPP) and erythrodermic psoriasis (EP) (NCT03051217). Methods: Patients ...
4.
Imafuku S, Tada Y, Umezawa Y, Sakurai S, Hoshii N, Nakagawa H
Dermatol Ther (Heidelb)
. 2021 Nov;
12(1):121-135.
PMID: 34826124
Introduction: We present certolizumab pegol (CZP) efficacy data across patient demographic and baseline disease characteristic subgroups from a phase 2/3 trial investigating CZP treatment in Japanese patients with moderate to...
5.
Umezawa Y, Asahina A, Imafuku S, Tada Y, Sano S, Morita A, et al.
Dermatol Ther (Heidelb)
. 2021 Apr;
11(3):943-960.
PMID: 33886085
Introduction: Certolizumab pegol (CZP), an Fc-free, PEGylated anti-tumour necrosis factor biologic, dosed at 400 mg every 2 weeks (Q2W) and 200 mg Q2W over 16 weeks, resulted in improvements in...
6.
Umezawa Y, Sakurai S, Hoshii N, Nakagawa H
Dermatol Ther (Heidelb)
. 2021 Feb;
11(2):513-528.
PMID: 33606269
Introduction: Certolizumab pegol (CZP), the Fc-free, PEGylated anti-tumor necrosis factor, is approved for the treatment of moderate to severe plaque psoriasis (PSO) in Western countries and in Japan, among other...
7.
Kobe D, Moriyasu H, Aihara Y, Tsuro K, Takeda K, Maekawa Y, et al.
Nihon Shokakibyo Gakkai Zasshi
. 2010 Nov;
107(11):1798-805.
PMID: 21071897
A 81-year-old woman admitted with general fatigue was found to have a giant polyp in the gastric antrum by endoscopy. The polyp prolapsed into the duodenum through the pylorus. Angiographic...
8.
Tsuro K, Matsumoto M, Moriyasu H, Nakatani Y, Sakurai S, Maekawa Y, et al.
Dig Endosc
. 2010 Jul;
22(3):246-7.
PMID: 20642620
No abstract available.
9.
Tsujimoto T, Fujii H, Kawaratani H, Sakurai S, Kojima H, Fukui H
Indian J Gastroenterol
. 2009 Jun;
28(1):33-4.
PMID: 19529901
Endoscopic retrieval of foreign bodies is sometimes a challenging task. We report a case of simultaneous removal of 5 coins from the stomach without causing mucosal injury using a specially-designed...
10.
Kojima H, Sakurai S, Uemura M, Kitamura K, Kanno H, Nakai Y, et al.
J Gastroenterol Hepatol
. 2007 Aug;
23(7 Pt 2):e120-8.
PMID: 17725603
Background And Aim: Endocytic retrieval of multidrug resistance protein 2 (MRP2) is closely associated with cholestasis and may be attributed to the disturbed linking of MRP2 and radixin, a cross-linker...